Development of a combinatory filtration system for pollution and virus abatement by optimized nanoparticle deposition.
PLoS One
; 17(3): e0264991, 2022.
Article
in English
| MEDLINE | ID: covidwho-1910556
ABSTRACT
PM2.5, particulate matter less than 2.5 microns, is the leading contributor to air pollution which results in cardio-vascular and respiratory diseases. Recent studies also indicate a strong correlation between ambient air pollution and COVID-19 cases, which have affected the lives of billions of people globally. Abatement technologies such as ionic and other high efficiency filtration systems are expensive and unaffordable in communities with limited resources. The goal of this study was to develop a mask with an optimized nanoparticle coating which has a dual capability of particulate matter and virus filtration, while being affordable and safe for human use. The nanoparticles were selected for their filtration and virucidal capabilities. Particle filtration efficiency, tested with a wind tunnel and PM2.5 from incense sticks measured by laser particle detectors, improved by ~60% with nanoparticle coatings on KN95 and surgical masks. Virus filtration efficiency, tested using nebulized NaCl particles as a virus surrogate, improved by 95% with coated masks. The nanoparticle retention efficacy, tested by simulating a normal 8-hour workday, was well within the permissible exposure limits. This technology has several applications such as in personal protective equipment for virus protection, and in air-conditioning and car cabin filters for pollution abatement. In conclusion, the chosen combination of nanoparticles provides an effective and safe solution for both particulate matter and viral particle filtration.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Air Pollution
/
Nanoparticles
/
COVID-19
Type of study:
Observational study
Limits:
Humans
Language:
English
Journal:
PLoS One
Journal subject:
Science
/
Medicine
Year:
2022
Document Type:
Article
Affiliation country:
Journal.pone.0264991
Similar
MEDLINE
...
LILACS
LIS